- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Pharmacy-Driven Challenges
Panelists discuss how pharmacy-related delays and limited escalation practices widen LDL-C management gaps.
Panelists discuss how pharmacy-driven barriers, including delayed statin initiation and failure to escalate therapy, contribute to the widening low-density lipoprotein cholesterol (LDL-C) treatment gap. Many patients do not receive statins promptly after diagnosis, and follow-up titration or add-on therapy often lags.
They note that pharmacists are well-positioned to intervene but face formulary restrictions, lack of collaborative authority, and communication barriers with prescribers. The pharmacy pipeline’s role in ensuring timely medication access is critical but underutilized.
Panelists advocate for enhanced pharmacist-led protocols, real-time prescription monitoring, and payer reforms to streamline therapy initiation and intensification.
Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid
November 6th 2025For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.
Read More
